Gordian Surgical Completes $1 Million Raise - KMPH FOX 26 | Central San Joaquin Valley News Source

Gordian Surgical Completes $1 Million Raise

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Gordian Surgical

TEL AVIV, Israel, April 29, 2014 /PRNewswire/ --

Gordian Surgical, a portfolio company of Trendlines Medical, recently completed a $1 million raise. Participants in the raise included angel investors, surgeons, and a private investment fund. Due to the interest in the Gordian technology, not only was the raise accomplished quickly but it exceeded the target by 30%.

Gordian's two-in-one trocar with a built-in closure device offers a safe, economical approach for opening and suturing abdominal incisions during laparoscopic procedures. Instead of inserting the sutures at the end of the procedure, using Gordian's uniquely designed release mechanism sutures are inserted into the tissue surrounding the opening at the beginning of the procedure. The sutures and anchors to hold them stay in place throughout the operation the incisions are closed efficiently when the Gordian trocar is removed.

An estimated 4.4 million laparoscopic procedures are performed annually in the United States. While laparoscopic procedures offer a minimally invasive surgical option, closing the numerous access ports (openings) remains a challenging, time-consuming task. Gordian Surgical's novel trocar provides a straightforward solution to this challenge.

Zvi Pe'er, CEO of Gordian Surgical, remarks: "I am extremely pleased by the level of interest in our technology and the speed with which we closed the investment round. The fact that three surgeons made investments and recommendations from other surgeons support the clinical need and strongly reinforce the solution that we are developing."

The funds will be used to finalize product design, receive regulatory clearance (FDA and CE mark), and perform clinical validations.

Eran Feldhay, CEO of Trendlines Medical, adds: "In a relatively short time, Gordian Surgical has made amazing strides and achievements. We are proud of this young company that has the capability of bringing a truly innovative solution to the operating theater."

About The Trendlines Group 

The Trendlines Group (http://www.trendlines.com) invests in, incubates, and supports early-stage, medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Trendlines Medical, our investment unit for medical innovation, works in partnership with innovators and investors, in an environment that encourages curiosity and fosters collaboration. Simply stated, Trendlines creates and develops companies to improve the human condition.

Media relations:
Efrat Kaduri

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KMPH. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.